These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11915581

  • 1. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.
    Strowitzki T, Halser B, Demant T.
    Gynecol Endocrinol; 2002 Feb; 16(1):45-51. PubMed ID: 11915581
    [Abstract] [Full Text] [Related]

  • 2. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 4. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J, Bergh T, Berne C, Lithell H.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [Abstract] [Full Text] [Related]

  • 5. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [Abstract] [Full Text] [Related]

  • 6. Lipid and lipoprotein profile in women with polycystic ovary syndrome.
    Macut D, Panidis D, Glisić B, Spanos N, Petakov M, Bjekić J, Stanojlović O, Rousso D, Kourtis A, Bozić I, Damjanović S.
    Can J Physiol Pharmacol; 2008 Apr; 86(4):199-204. PubMed ID: 18418429
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 8. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P.
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [Abstract] [Full Text] [Related]

  • 9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 10. Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity?
    Wijeyaratne CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R, Belchetz PE.
    Clin Endocrinol (Oxf); 2004 May; 60(5):560-7. PubMed ID: 15104558
    [Abstract] [Full Text] [Related]

  • 11. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 12. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
    Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N.
    Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
    [Abstract] [Full Text] [Related]

  • 13. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
    Uncu G, Ozyurek SE, Uncu Y.
    Fertil Steril; 2007 Sep; 88(3):670-4. PubMed ID: 17451692
    [Abstract] [Full Text] [Related]

  • 14. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females.
    García-Lorda P, Bulló M, Vilà R, del Mar Grasa M, Alemany M, Salas-Salvadó J.
    Diabetes Nutr Metab; 2001 Dec; 14(6):329-36. PubMed ID: 11853365
    [Abstract] [Full Text] [Related]

  • 15. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
    Glintborg D, Andersen M, Richelsen B, Bruun JM.
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):652-8. PubMed ID: 19170716
    [Abstract] [Full Text] [Related]

  • 16. Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome.
    Berria R, Gastaldelli A, Lucidi S, Belfort R, De Filippis E, Easton C, Brytzki R, Cusi K, Jovanovic L, DeFronzo R.
    Clin Pharmacol Ther; 2006 Aug; 80(2):105-14. PubMed ID: 16890572
    [Abstract] [Full Text] [Related]

  • 17. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
    Noyan V, Yucel A, Sagsoz N.
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug 10; 115(2):200-5. PubMed ID: 15262356
    [Abstract] [Full Text] [Related]

  • 18. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES, Drews CD, Perloe M, Tucker MJ, Kaplan CR, Palermo GD.
    Gynecol Endocrinol; 2003 Jun 10; 17(3):231-7. PubMed ID: 12857431
    [Abstract] [Full Text] [Related]

  • 19. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M, Neary RH, Kumpatla P, Game FL, Jones PW, Obhrai MS, Clayton RN.
    J Clin Endocrinol Metab; 1997 Oct 10; 82(10):3389-94. PubMed ID: 9329374
    [Abstract] [Full Text] [Related]

  • 20. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 10; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.